Already a member? Sign in
Category: Over the Counter Drugs
Most Popular Types: Claritin, Alavert Allergy, Claratyne (Show all)
Loratadine is an over the counter medication used for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and for the treatment of chronic idiopathic urticaria (itching).
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Allergies | 113 | 25 |
|
|
|
|
|
| Seasonal Allergy | 51 | 5 |
|
|
|||
| Perennial Allergy | 33 | 5 |
|
|
|
||
| Seasonal allergy | 30 | 6 |
|
|
|
|
|
| Other | 28 | 6 |
|
|
|
||
| Allergic Rhinitis | 18 | 1 |
|
See all 238 patients currently taking Loratadine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Loratadine
| Sleepiness | 3 | |
|---|---|---|
| Dry mouth (xerostomia) | 3 | |
| Dry throat | 1 | |
| Daytime sleepiness | 1 | |
| Migraine headaches | 1 | |
| Nausea | 1 | |
| See all 8 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Loratadine. See all 17 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 23 | ||
| Course of treatment ended | 23 | ||
| Other | 19 | ||
| Doctor's advice | 9 | ||
| Side effects too severe | 6 | ||
| Expense | 6 | ||
| Personal research | 3 | ||
| Change in health plan coverage | 2 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Loratadine
Always |
32 | 57% |
|
|---|---|---|---|
Usually |
16 | 29% |
|
Sometimes |
6 | 11% |
|
Never |
2 | 4% |
|
Burden
Difficulty being on treatment
Burden of Loratadine
Very |
1 | 2% |
|
|---|---|---|---|
Somewhat |
1 | 2% |
|
A little |
8 | 14% |
|
Not at all |
46 | 82% |
|
Cost
Paid out of pocket
Cost of Loratadine
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
1 | 3% |
|
$50-99 |
1 | 3% |
|
$25-49 |
4 | 11% |
|
< $25 |
31 | 84% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 12, 2012.